Tantum verde tab. d / rassas. 3mg # 20

Release form, composition and packaging

?

Lozenges, green mint flavor, translucent, square, with a depression in the center, with a characteristic mint-lemon odor.

1 tab.

benzydamine hydrochloride 3 mg

isomaltose - 3183 mg, levomenthol - 4 mg, aspartame - 3.5 mg, citric acid monohydrate - 2 mg, mint flavor - 5 mg, lemon flavor - 1.5 mg, quinoline yellow dye (E104) - 0.035 mg, indigo carmine dye (E132) - 0.015 mg.

1 PC.

- wrappers from waxed paper (10) - wrappers from two-layer aluminum foil (2) - cardboard packs.

pharmachologic effect

Benzydamine is a non-steroidal anti-inflammatory drug (NSAID), belongs to the indazole group. It has anti-inflammatory and local anesthetic effect, has an antiseptic effect against a wide range of microorganisms. The mechanism of action of the drug is associated with the stabilization of cell membranes and inhibition of prostaglandin synthesis. Benzydamine has an antibacterial and specific antimicrobial effect due to the rapid penetration of microorganisms through membranes with subsequent damage to cellular structures, disruption of metabolic processes and cell lysosomes. Has antifungal action against Candida albicans. It causes structural modifications of the cell wall of fungi and their metabolic chains, thus interfering with their reproduction,which was the basis for the use of benzydamine in inflammatory processes in the oral cavity, including infectious etiology.

Pharmacokinetics

When applied topically, the drug is well absorbed through the mucous membranes and penetrates into the inflamed tissues, it is found in the blood plasma in an amount insufficient to obtain systemic effects.

Excretion of the drug occurs mainly by the kidneys, in the form of inactive metabolites or conjugation products.

Indications for use

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies): - gingivitis, glossitis, stomatitis (including after radiation and chemotherapy)

- pharyngitis, laryngitis, tonsillitis

- candidiasis of the oral mucosa (as part of combination therapy)

- calculous inflammation of the salivary glands

- after surgical interventions and injuries (tonsillectomy, jaw fractures)

- after treatment and tooth extraction

- periodontal disease.

In case of infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum® Verde as part of a combination therapy.

Contraindications for use

- phenylketonuria, because

the product contains aspartame (for lozenges with peppermint or lemon flavor)

- fructose intolerance

- children under 6 years old

- hypersensitivity to benzydamine or other components of the drug.

Precautions: hypersensitivity to acetylsalicylic acid or other NSAIDs

bronchial asthma (including history).

Dosage regimen

The drug is used topically after meals.

The tablets should be kept in the mouth until they are completely dissolved, do not swallow or chew.

Adults (including elderly patients) and children over 6 years old are prescribed 1 tab.

for resorption 3 times / day.

Do not exceed the recommended dose.

In children aged 6 to 12 years, the use of the drug is carried out under the supervision of an adult.

The duration of treatment should not exceed 7 days.

If after treatment within 7 days there is no improvement or new symptoms appear, the patient should consult a doctor.

Overdose

Currently, no cases of overdose of Tantum® Verde have been reported.

When using the drug in accordance with the instructions, overdose is unlikely.

Symptoms: if the drug is accidentally swallowed, the following symptoms are possible - vomiting, abdominal cramps, anxiety, fear, hallucinations, convulsions,

Name ENG

TANTUM VERDE

Clinical and pharmacological group

NSAIDs for topical use in ENT practice and dentistry

ATX code

Benzydamine

Dosage

3mg

Structure

For one lozenge: The active ingredient is benzydamine hydrochloride - 3 mg.

Auxiliary ingredients: isomaltose 3183 mg, racementol 4 mg, aspartame 3.5 mg, citric acid, monohydrate 2 mg, mint flavor 5 mg, lemon flavor 1.5 mg, quinoline yellow dye (E104) 0.035 mg, indigo carmine dye (E132) 0.015 mg.

Indications

Symptomatic therapy of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies): - gingivitis, glossitis, stomatitis (including after radiation and chemotherapy)

-pharyngitis, laryngitis, tonsillitis

- candidiasis of the oral mucosa (as part of combination therapy)

-calculous inflammation of the salivary glands

-after surgical interventions and injuries (tonsillectomy, jaw fractures) -after the treatment and tooth extraction

- periodontal disease

For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum Verde as part of a combination therapy.

INN / Active ingredient

benzydamine hydrochloride

Storage conditions and periods

In a dark place at a temperature not exceeding 25 degrees.

Expiration date: 4 years

Contraindications

hypersensitivity to benzydamine or other components of the drug

- fructose intolerance

- children under 6 years old

- phenylketonuria, because

contains aspartame (for mint-flavored or lemon-flavored lozenges) Precautions Hypersensitivity to acetylsalicylic acid or other nonsteroidal anti-inflammatory drugs, bronchial asthma (including history).

Application during pregnancy and during breastfeeding Tantum® Verde should not be used during pregnancy and during breastfeeding.

Specifications

Category

Sore throat

Scope of the drug

Ear, Throat, Nose

Release form

Tablet

Manufacturer country

Switzerland

Package quantity, pcs

twenty

Minimum age from

6 years

Way of introduction

Through the mouth

Vacation conditions

Without recipe

Brand name

Tantum

The amount of the dosage form in the primary package

1 PC.

Primary packaging type

Paper

Type of consumer packaging

Pack of cardboard

Pharmaco-therapeutic group

NSAIDs

Anatomical and therapeutic characteristics

A01AD02 Benzidamine

Dosage form

Lozenges, [mint]

Dosage (volume) of the substance in the preparation

benzydamine hydrochloride 3 mg

The target audience

Children

Expiration date in days

1460

Package weight, g

fifty

Mode of application

:

Locally, after eating. Adults (including elderly patients) and children over 6 years old: 1 lozenge 3 times a day. Keep the tablets in the mouth until completely dissolved. < br> < br> Do not swallow. Do not chew. Do not exceed the recommended dose. For children from 6 to 12 years old, the use of the drug is carried out under the supervision of an adult. < br> < br> The duration of treatment should not exceed 7 days. If after treatment within 7 days there is no improvement or new symptoms appear, you should consult your doctor. < br> < br> Use the drug only according to the method of application and in the doses indicated in the instructions. If necessary, please consult your doctor before using the medicinal product.

Information on technical characteristics, delivery set, country of manufacture